ESC 365
Menu
Home
Search
Events
About
ESC Platforms
Escardio.org
ESC 365
ESC eLearning
Create an account
Sign in
Back
Open Access
SGLT2 inhibition and heart failure: a different way of thinking?
Session:
SGLT2 inhibition and heart failure: a different way of thinking? (EBAC Accredited)
Topic:
Epidemiology, Prognosis, Outcome
Speaker:
Professor A. Voors (Groningen, NL)
Associate Professor M. Cavender (Chapel Hill, US)
Professor R. De Boer (Rotterdam, NL)
Professor T. McDonagh (London, GB)
Sponsored by AstraZeneca
Event:
ESC Congress 2018
Congress Presentation
Sign in to view the resources
Sign in to view the resources
About the speakers
Professor Adriaan Voors
University Medical Centre Groningen, Groningen (Netherlands (The))
77
presentations
1
follower
Associate Professor Matthew Cavender
University of North Carolina Hospitals, Chapel Hill (United States of America)
6
presentations
0
follower
Professor Rudolf De Boer
Erasmus University Medical Centre, Rotterdam (Netherlands (The))
58
presentations
5
followers
Professor Theresa McDonagh
King's College Hospital, London (United Kingdom of Great Britain & Northern Ireland)
60
presentations
33
followers
Access the full session
SGLT2 inhibition and heart failure: a different way of thinking? (EBAC Accredited)
Speakers:
Professor A. Voors, Associate Professor M. Cavender, Professor R. De Boer, Professor T. McDonagh
Access
About the event
ESC Congress 2018
7 November - 29 August 2018
Sessions
Presentations
ESC 365 is supported by
Explore sponsored resources